Welcome to our dedicated page for JWS news (Ticker: JWS), a resource for investors and traders seeking the latest updates and insights on JWS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JWS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JWS's position in the market.
Cano Health has successfully completed its business combination with Jaws Acquisition Corp. (JWS) as of June 3, 2021. This merger, approved by Jaws' stockholders, is expected to accelerate Cano Health's growth in value-based primary care for seniors and underserved communities. Effective June 4, 2021, Cano Health's shares will trade on the NYSE under the symbol 'CANO.' The company secured approximately $1.49 billion in gross proceeds from the merger, which will support its expansion plans and enhance the delivery of high-quality primary care.
Jaws Acquisition Corp. (NYSE: JWS) has announced an extraordinary general meeting scheduled for June 2, 2021, at 9:00 a.m. New York City Time. Due to COVID-19 concerns, shareholders are encouraged to attend via teleconference. The meeting will focus on voting for proposals related to the merger with Cano Health, LLC, following a Business Combination Agreement established on November 11, 2020. The definitive proxy statement/prospectus has been mailed to shareholders, providing essential details regarding the proposed business combination.
Jaws Acquisition Corp. (NYSE: JWS) announced the effectiveness of its Registration Statement for the merger with Cano Health, LLC. A special meeting for shareholders is scheduled for June 2, 2021, to approve the merger. If approved, the merger will be finalized on June 3, 2021, with the new ticker symbol 'CANO'. Barry Sternlicht, Co-Founder of Jaws, highlighted the merger's potential to leverage value-based care opportunities and demographic trends, positioning Cano Health for significant growth.
Cano Health has announced the formation of its Board of Directors following its business combination with Jaws Acquisition Corp. (NYSE: JWS). The board features diverse professionals from healthcare, technology, and finance, including Dr. Marlow Hernandez, who will serve as Chairman. The strategic expertise of board members, such as Elliot Cooperstone and Barry Sternlicht, is expected to support Cano Health’s growth as a publicly-traded company. Cano Health, which operates over 70 medical centers across multiple states, focuses on value-based primary care for seniors.
Cano Health, a leading value-based care platform for seniors, and Jaws Acquisition Corp. (NYSE: JWS) will host a virtual Investor and Analyst Day on March 4, 2021, from 10:00 a.m. to 1:00 p.m. ET. This follows the announcement on November 12, 2020 regarding their merger, projected to finalize in Q2 2021, with Cano Health subsequently listed under the ticker 'CANO' on the NYSE. Event registration is available via email, and a live webcast will be accessible online.
